LG Chem, Ltd.
Seoul, Korea, Republic of
Purpose
to fund clinical trial studies for developing the new Sabin Inactivated Polio Virus (IPV) candidate, in addition to installation of IPV production facility, to expand supply to GAVI eligible countries at an affordable price
Division
Global Development
Date
May 2017
Region Served
GLOBAL
Committed amount
$28,046,386
Grant topic
Polio
Duration (months)
106
Grantee location
Seoul, Korea, Republic of
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.